Virpax Pharmaceuticals (VRPX) Institutional Ownership → Could Bitcoin Literally FORCE This Crypto To Rocket Up? (From Paradigm Press) (Ad) Free VRPX Stock Alerts $3.47 0.00 (0.00%) (As of 04/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Virpax Pharmaceuticals (NASDAQ:VRPX)CurrentInstitutional OwnershipPercentage32.23%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$3.11M Get VRPX Insider Trade Alerts Want to know when executives and insiders are buying or selling Virpax Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data VRPX Institutional Buying and Selling by Quarter Ad Paradigm PressCould Bitcoin Literally FORCE This Crypto To Rocket Up?Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. Virpax Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2023Sabby Management LLC292,790$234K0.2%-26.8%2.500% 5/16/2023Sabby Management LLC701,455$551K0.5%-29.0%5.988% 2/13/2023Renaissance Technologies LLC96,200$60K0.0%-39.2%0.822% 11/15/2022Vanguard Group Inc.370,884$441K0.0%+8.5%3.166% 11/14/2022Renaissance Technologies LLC158,322$188K0.0%-22.1%1.352% 8/13/2022Renaissance Technologies LLC203,200$341K0.0%+29.8%1.735% 5/13/2022Renaissance Technologies LLC156,600$348K0.0%N/A1.337% 5/13/2022Vanguard Group Inc.341,977$759K0.0%+4.5%2.918% 5/13/2022Warberg Asset Management LLC17,710$39K0.0%N/A0.151% 5/12/2022Citigroup Inc.12,179$27K0.0%N/A0.104% 11/17/2021Altium Capital Management LP271,846$1.31M0.3%N/A2.320% 11/16/2021National Asset Management Inc.18,600$90K0.0%N/A0.159% 11/2/2021Cambridge Investment Research Advisors Inc.19,420$93K0.0%N/A0.166% 9/17/2021Virtu Financial LLC23,625$107K0.0%N/A0.468% 8/16/2021Sabby Management LLC154,737$704K0.1%-22.6%3.120% 8/12/2021Saltoro Capital LP17,615$80K0.0%-34.8%0.355% 5/14/2021HN Saltoro Capital LP27,000$127K0.0%N/A0.546% (Data available from 1/1/2016 forward) VRPX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VRPX shares? During the previous two years, the following institutional investors and hedge funds held shares of Virpax Pharmaceuticals shares: Vanguard Group Inc. ($441K), Sabby Management LLC ($234K), Renaissance Technologies LLC ($60K), and Warberg Asset Management LLC ($39K), Citigroup Inc. ($27K).Learn more on VRPX's institutional investors. What percentage of Virpax Pharmaceuticals stock is owned by institutional investors? 32.23% of Virpax Pharmaceuticals stock is owned by institutional investors. Learn more on VRPX's institutional investor holdings. Which institutional investors have been buying Virpax Pharmaceuticals stock? The following institutional investors have purchased Virpax Pharmaceuticals stock in the last 24 months: Renaissance Technologies LLC ($203.20K), Vanguard Group Inc. ($43.58K), Warberg Asset Management LLC ($17.71K), and Citigroup Inc. ($12.18K). How much institutional buying is happening at Virpax Pharmaceuticals? Institutional investors have bought a total of 276,668 shares in the last 24 months. This purchase volume represents approximately $5.59M in transactions. Which Virpax Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Virpax Pharmaceuticals stock in the last 24 months: Sabby Management LLC ($393.92K), and Renaissance Technologies LLC ($107K). How much institutional selling is happening at Virpax Pharmaceuticals? Institutional investors have sold a total of 500,920 shares in the last 24 months. This volume of shares sold represents approximately $4.03M in transactions. Related Companies: REVB Major Shareholders NEXI Major Shareholders LIPO Major Shareholders KA Major Shareholders PXMD Major Shareholders SNGX Major Shareholders THAR Major Shareholders ARDS Major Shareholders BCEL Major Shareholders CING Major Shareholders This page (NASDAQ:VRPX) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold[Urgent!] Generational Wealth GameplanCrypto 101 MediaIRS Loophole Gives Americans An Escape From InflationBirch GoldThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsThe “Perfect Storm” for GoldGold Safe ExchangeThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virpax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.